| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Obstetrics, Gynecology and Reproductive Science (C.S.), Yale University School of Medicine, New Haven, Connecticut 06510; Division of Basic Biomedical Sciences (C.T.), Sanford School of Medicine of the University of South Dakota, Vermillion, South Dakota 57069; and Department of Physiology and Biophysics (G.G.), University of Illinois College of Medicine, Chicago, Illinois 60612
Correspondence: Address all correspondence and requests for reprints to: Dr. Geula Gibori, Department of Physiology and Biophysics, University of Illinois College of Medicine, 835 South Wolcott Avenue, Chicago, Illinois 60612. E-mail: ggibori{at}uic.edu
The corpus luteum (CL) is one of the few endocrine glands that forms from the remains of another organ and whose function and survival are limited in scope and time. The CL is the site of rapid remodeling, growth, differentiation, and death of cells originating from granulosa, theca, capillaries, and fibroblasts. The apparent raison detre of the CL is the production of progesterone, and all the structural and functional features of this gland are geared toward this end. Because of its unique importance for successful pregnancies, the mammals have evolved a complex series of checks and balances that maintains progesterone at appropriate levels throughout gestation. The formation, maintenance, regression, and steroidogenesis of the CL are among the most significant and closely regulated events in mammalian reproduction. During pregnancy, the fate of the CL depends on the interplay of ovarian, pituitary, and placental regulators. At the end of its life span, the CL undergoes a process of regression leading to its disappearance from the ovary and allowing the initiation of a new cycle. The generation of transgenic, knockout and knockin mice and the development of innovative technologies have revealed a novel role of several molecules in the reprogramming of granulosa cells into luteal cells and in the hormonal and molecular control of the function and demise of the CL. The current review highlights our knowledge on these key molecular events in rodents.
This article has been cited by other articles:
![]() |
R S Robinson, K J Woad, A J Hammond, M Laird, M G Hunter, and G E Mann Angiogenesis and vascular function in the ovary Reproduction, December 1, 2009; 138(6): 869 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Edson, A. K. Nagaraja, and M. M. Matzuk The Mammalian Ovary from Genesis to Revelation Endocr. Rev., October 1, 2009; 30(6): 624 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Clapp, S. Thebault, M. C. Jeziorski, and G. Martinez De La Escalera Peptide Hormone Regulation of Angiogenesis Physiol Rev, October 1, 2009; 89(4): 1177 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T Anderson, N. N M Isa, J. L Barclay, M. J Waters, and J. D Curlewis Maximal expression of suppressors of cytokine signaling in the rat ovary occurs in late pregnancy Reproduction, September 1, 2009; 138(3): 537 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bachelot, J. Beaufaron, N. Servel, C. Kedzia, P. Monget, P. A. Kelly, G. Gibori, and N. Binart Prolactin independent rescue of mouse corpus luteum life span: identification of prolactin and luteinizing hormone target genes Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E676 - E684. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Devi, A. Shehu, C. Stocco, J. Halperin, J. Le, A. M. Seibold, M. Lahav, N. Binart, and G. Gibori Regulation of Transcription Factors and Repression of Sp1 by Prolactin Signaling Through the Short Isoform of Its Cognate Receptor Endocrinology, July 1, 2009; 150(7): 3327 - 3335. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Peters, D. D. Seachrist, R. A. Keri, and G. C. Sen The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation PNAS, June 30, 2009; 106(26): 10696 - 10701. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jimenez-Krassel, J.K. Folger, J.L.H. Ireland, G.W. Smith, X. Hou, J.S. Davis, P. Lonergan, A.C.O. Evans, and J.J. Ireland Evidence That High Variation in Ovarian Reserves of Healthy Young Adults Has a Negative Impact on the Corpus Luteum and Endometrium During Estrous Cycles in Cattle Biol Reprod, June 1, 2009; 80(6): 1272 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gaytan, M. Gaytan, J. M. Castellano, M. Romero, J. Roa, B. Aparicio, N. Garrido, J. E. Sanchez-Criado, R. P. Millar, A. Pellicer, et al. KiSS-1 in the mammalian ovary: distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E520 - E531. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, F. Jimenez-Krassel, J. J Ireland, and G. W Smith Gene expression profiling of bovine preovulatory follicles: gonadotropin surge and prostanoid-dependent up-regulation of genes potentially linked to the ovulatory process Reproduction, February 1, 2009; 137(2): 297 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ben-Ami, L. Armon, S. Freimann, D. Strassburger, R. Ron-El, and A. Amsterdam EGF-like growth factors as LH mediators in the human corpus luteum Hum. Reprod., January 1, 2009; 24(1): 176 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Myers, S. van den Driesche, A. S McNeilly, and W C. Duncan Activin A reduces luteinisation of human luteinised granulosa cells and has opposing effects to human chorionic gonadotropin in vitro J. Endocrinol., November 1, 2008; 199(2): 201 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Fan, Z. Liu, N. Cahill, and J. S. Richards Targeted Disruption of Pten in Ovarian Granulosa Cells Enhances Ovulation and Extends the Life Span of Luteal Cells Mol. Endocrinol., September 1, 2008; 22(9): 2128 - 2140. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Anupriwan, M. Schenk, K. Kongmanas, R. Vanichviriyakit, D. Costa Santos, A. Yaghoubian, F. Liu, A. Wu, T. Berger, K. F. Faull, et al. Presence of Arylsulfatase A and Sulfogalactosylglycerolipid in Mouse Ovaries: Localization to the Corpus Luteum Endocrinology, August 1, 2008; 149(8): 3942 - 3951. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gonzalez-Fernandez, E. Martinez-Galisteo, F. Gaytan, J. A. Barcena, and J. E. Sanchez-Criado Changes in the Proteome of Functional and Regressing Corpus Luteum During Pregnancy and Lactation in the Rat Biol Reprod, July 1, 2008; 79(1): 100 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhao, A. De, Z. Hu, J. Li, S. M. Mulders, M. D. Sollewijn Gelpke, E.-K. Duan, and A. J. W. Hsueh Gonadotropin Stimulation of Ovarian Fractalkine Expression and Fractalkine Augmentation of Progesterone Biosynthesis by Luteinizing Granulosa Cells Endocrinology, June 1, 2008; 149(6): 2782 - 2789. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-S. Park, S. Choi, K. N. Muse, T. E. Curry Jr., and M. Jo Response Gene to Complement 32 Expression Is Induced by the Luteinizing Hormone (LH) Surge and Regulated by LH-Induced Mediators in the Rodent Ovary Endocrinology, June 1, 2008; 149(6): 3025 - 3036. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-U. Chen, C.-H. Chou, H. Lee, C.-H. Ho, C.-W. Lin, and Y.-S. Yang Lysophosphatidic Acid Up-Regulates Expression of Interleukin-8 and -6 in Granulosa-Lutein Cells through Its Receptors and Nuclear Factor-{kappa}B Dependent Pathways: Implications for Angiogenesis of Corpus Luteum and Ovarian Hyperstimulation Syndrome J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 935 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee What Can We Learn from Rodents about Prolactin in Humans? Endocr. Rev., February 1, 2008; 29(1): 1 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hou, E. W. Arvisais, C. Jiang, D.-b. Chen, S. K. Roy, J. L. Pate, T. R. Hansen, B. R. Rueda, and J. S. Davis Prostaglandin F2{alpha} Stimulates the Expression and Secretion of Transforming Growth Factor B1 Via Induction of the Early Growth Response 1 Gene (EGR1) in the Bovine Corpus Luteum Mol. Endocrinol., February 1, 2008; 22(2): 403 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Del Canto, W. Sierralta, P. Kohen, A. Munoz, J. F. Strauss III, and L. Devoto Features of Natural and Gonadotropin-Releasing Hormone Antagonist-Induced Corpus Luteum Regression and Effects of in Vivo Human Chorionic Gonadotropin J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4436 - 4443. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Peluffo, R. L. Stouffer, and M. Tesone Activity and expression of different members of the caspase family in the rat corpus luteum during pregnancy and postpartum Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1215 - E1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stocco, J. Kwintkiewicz, and Z. Cai Identification of regulatory elements in the Cyp19 proximal promoter in rat luteal cells J. Mol. Endocrinol., October 1, 2007; 39(4): 211 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Miranda-Jimenez and B. D. Murphy Lipoprotein receptor expression during luteinization of the ovarian follicle Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1053 - E1061. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |